Respiratory syncytial virus (RSV) is a single-stranded negative-sense RNA virus that is the
primary etiologic pathogen of bronchitis and pneumonia in infants and the elderly. Currently …

Respiratory syncytial virus (RSV) is responsible for a significant proportion of global
morbidity and mortality affecting young children and older adults. In the aftermath of formalin …

Globally, respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and
pneumonia in young children, and the association between severe RSV disease and later …

Respiratory syncytial virus (RSV) can lead to serious disease in infants, and no approved
RSV vaccine is available for infants. This first in-human clinical trial evaluated a single dose …

Respiratory syncytial virus (RSV) is a highly contagious seasonal virus and the leading
cause of Lower Respiratory Tract Infections (LRTI), including pneumonia and bronchiolitis in …

Vaccination is an urgently needed and effective option to address epidemic, cancers,
allergies, and other diseases. Nasal administration of vaccines offers many benefits over …

Age-associated physiologic changes, unique geriatric syndromes, and frequent, prolonged
health care interactions make older adults uniquely vulnerable to infections. The …

Respiratory syncytial virus (RSV) is a lead cause of morbidity and hospitalizations in infants.
RSV vaccines are currently under development, and preventive options are limited to …

Respiratory viral infections account for a large percentage of global disease and death.
Respiratory syncytial virus is a seasonal virus affecting immunologically vulnerable …

Several respiratory pathogens are responsible for influenza-like illness (ILI) and severe
respiratory infections (SARI), among which human respiratory syncytial virus (hRSV) …